CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | May/June 2016

Radial PCI

The advantages and limitations of 4- to 5-F guide catheters.

By Tejas Patel, MD, DM, FACC, FSCAI, FESC, and Samir B. Pancholy, MD, FACP, FACC, FSCAI

cit | Article | May/June 2012

Choosing Catheter Shapes for Radial PCI

Considerations for selecting the right tool when using transradial access for percutaneous coronary intervention.

By Tejas Patel, MD, FACC, FSCAI; Sanjay Shah, MD; Samir Pancholy, MD, FACC, FSCAI; and Tak Kwan, MD, FACC, FACP, FSCAI

cit | Article | September/October 2016

Radial Access for Structural Intervention

A transradial approach can be utilized as a primary or secondary access strategy to reduce morbidity and major adverse cardiac events in various structural interventions.

By Kintur Sanghvi, MD; Richard Kovach, MD; and Tejas Patel, MD

cit | Article | September/October 2015

Ask the Experts: Uptake of radial access in the United States: A glass half full?

With James Nolan, MBChB, FRCP, MD; Samir B. Pancholy, MD, FACP, FACC, FSCAI; Tejas Patel, MD, DM, FACC, FSCAI, FESC; and Sunil V. Rao, MD

Advertisement

Advertisement

cit | Article | May/June 2012

Chief Medical Editor's Page

Radial Refinement

By Ted E. Feldman, MD, FSCAI, Chief Medical Editor

cit | News | May 18, 2020

Reduction in Patient Radiation Exposure Shown With Corindus' Robotic-Assisted Intervention

May 18, 2020—Corindus, a Siemens Healthineers Company, announced the publication of clinical results from a comparative study between robotic percutaneous coronary intervention (PCI) and manual PCI.

cit | News | December 5, 2018

Corindus' CorPath Technology Used in First-in-Human Telerobotic Coronary Intervention

December 6, 2018—Corindus Vascular Robotics, Inc. announced that its CorPath GRX technology was used to conduct the first-in-human (FIH) GRX With ReMOTE study.

cit | Article | September/October 2015

Optimal Access/Reliable Closure

By Ted E. Feldman, MD, MSCAI, FACC, FESC

cit | Article | May/June 2016

Bioresorbables Plus Access & Closure

By Ted E. Feldman, MD, MSCAI, FACC, FESC

cit | News | September 2, 2019

Results Published From FIH Telerobotic PCI Procedures With Corindus' CorPath GRX System

September 3, 2019—Corindus Vascular Robotics, Inc. announced results from the first-in-human (FIH) ReMOTE study on the telerobotic percutaneous coronary intervention (PCI) procedures conducted from a remote location outside the catheterization lab using the company's CorPath GRX robotic system technology platform.

cit | News | June 29, 2021

Abiomed’s Impella RP With SmartAssist Approved by FDA to Treat Right Heart Failure

June 29, 2021—Abiomed announced that its Impella RP with SmartAssist has received FDA premarket approval (PMA) as safe and effective to treat acute right heart failure for up to 14 days.

cit | News | September 30, 2009

Unprotected Left Main Coronary Intervention

In patients with significant obstructive left main coronary artery disease, initial studies showed that coronary artery bypass graft surgery (CABG) improved long-term survival compared with medical therapy.1-3 Since publication of these studies, CABG has been considered the standard of care for revascularization of left main coronary artery disease in the absence of previous bypass grafts to branches of the left coronary artery—so-called unprotected left main (ULM) revascularization.

cit | Article | May/June 2016

Transradial Catheterization: Hemostasis, Patency, and Same-Day Discharge

Transradial catheterization can lead to safer, less costly, and more satisfactory coronary angiography and interventions.

By Chad M. Dugas, MD, and Jeffrey M. Schussler, MD, FACC, FSCAI

cit | Article | January/February 2019

PCI in Patients With Cancer

Approaches for successfully treating this challenging patient population when invasive coronary procedures are needed.

By Ezequiel Munoz-Gonzalez, MD; Marie-France Poulin, MD; Mishita Goel, MD; Opeyemi Oyenusi, BSc; Cezar Iliescu, MD; and Tochi M. Okwuosa, DO

Sponsored by Covidien

cit | Article | September/October 2012 Supplement

The Case for Treating Venous Disease

Balancing the “red” and “blue” in practice.

By Ernesto Rivera, MD

cit | Article | May/June 2023

Systems of Care Approach to the Management of Cardiogenic Shock

Recent studies have demonstrated the merits of protocoled team-based care with regionalized shock networks in improving outcomes in cardiogenic shock.

By Raghav Gattani, MD; Carolyn M. Rosner, NP, MBA; and Behnam N. Tehrani, MD

cit | Article | March/April 2019

TAVR: General Anesthesia or Moderate Conscious Sedation?

A report of findings from registries and large cohorts.

By Hasan Rehman, MD; Neal S. Kleiman, MD, FACC, MSCAI; and Ankur Kalra, MD, FACP, FACC, FSCAI

cit | Article | March/April 2026

Next-Generation PERT Concepts: Ensuring Sustainability While Improving Care Pathways

Moderator Kenneth Rosenfield, MD, MHCDS, leads an expert conversation on sustaining PERT programs, preventing burnout, reducing therapeutic bias, integrating AI, and improving patient-centered PE care.

With Vivian L. Bishay, MD; Patrick Muck, MD; and Sameh Sayfo, MD, MBA, FSCAI, FACC

cit | Article | May/June 2014

2014 Updates to Treating Valvular Heart Disease

An expert panel discusses the multisocietal document on treating mitral regurgitation and changes to the practice guidelines.

With Ted E. Feldman, MD, FESC, FACC, FSCAI; Michael Reardon, MD, FACC, FACS; Paul Sorajja, MD, FACC, FAHA, FSCAI; and Carl Tommaso, MD, FACC, FSCAI, FAHA

cit | Article | September/October 2018

Diagnosing Gray Zone Coronary Physiology

Moderator: William F. Fearon, MD
Panel: Morton J. Kern, MD, MSCAI, FAHA, FACC; Nils P. Johnson, MD, MS; and John McBarron Hodgson, MD, MSCAI


1
2

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button